Orion is a globally operating Finnish pharmaceutical company – a builder of well-being.
We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. We believe that health and well-being create the foundation for a good life and society.
We are continuously developing new drugs and treatment methods. The core therapy areas of our pharmaceutical R&D are oncology and pain.
We collaborate closely with healthcare professionals and leading global research institutions and pharmaceutical companies.
Orion’s mission is to build well-being. Orion builds well-being by bringing to markets drugs and therapies from which patients get help for their illnesses. An effective drug or therapy also creates added value for patients by improving their quality of life.
The Orion Group organization is divided into five business divisions, responsible for commercial activities, and five group-level functions.